Acute stress disorder and C-reactive protein in patients with acute myocardial infarction

European Journal of Preventive Cardiology

Volumn 25, Issue 3, 2018, Pages 298-305

  Bielas, Hannes ^a,b   Meister Langraf, Rebecca E ^c,d   Schmid, Jean Paul ^e   Barth, Jürgen ^a   Znoj, Hansjörg ^c   Schnyder, Ulrich ^a   Princip, Mary ^b,c   von Känel, Roland ^b,c,e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Clinic Fontane   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d Private Psychiatric and Psychotherapy Clinic   (Switzerland)

^e Clinic Barmelweid   (Switzerland)

Author keywords

Cardiovascular disease; inflammation; psychobiology; risk factor; trauma stress

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIVALIRUDIN; C REACTIVE PROTEIN; CLOPIDOGREL; EPTIFIBATIDE; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; PRASUGREL; TICAGRELOR; TIROFIBAN; TROPONIN; TROPONIN T; AUTACOID; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ACUTE STRESS DISORDER; ADULT; ARTICLE; BODY MASS; DSM-IV; FEMALE; FIBRINOLYTIC THERAPY; HEALTH BEHAVIOR; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADOLESCENT; AGED; BLOOD; COMPLICATION; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROGNOSIS; PSYCHOLOGY; RISK FACTOR; UPREGULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NON-ST ELEVATED MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; STRESS DISORDERS, TRAUMATIC, ACUTE; UP-REGULATION; YOUNG ADULT;

EID: 85041635772     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487317748506     Document Type: Article

References (33)

1. Ginzburg K, Solomon Z, Koifman B, Trajectories of posttraumatic stress disorder following myocardial infarction: A prospective study. J Clin Psychiatry 2003; 64: 1217–1223.
2. Bryant RA. Acute stress disorder as a predictor of posttraumatic stress disorder. J Clin Psychiatry 2011; 72: 233–239.
3. Ginzburg K, Ein-Dor T. Posttraumatic stress syndromes and health-related quality of life following myocardial infarction: 8-year follow-up. Gen Hosp Psychiatry 2011; 33: 565–571.
4. Von Känel R, Hari R, Schmid JP, Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol 2011; 58: 61–68.
5. Edmondson D, Rieckmann N, Shaffer JA, Posttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortality. J Psychiatr Res 2011; 45: 1621–1626.
6. Rizzo M, Corrado E, Coppola G, Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis. J Invest Med 2008; 56: 32–40.
7. Baker DG, Nievergelt CM, O’Connor DT. Biomarkers of PTSD: Neuropeptides and immune signaling. Neuropharmacology 2012; 62: 663–673.
8. Spitzer C, Barnow S, Völzke H, Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: Evidence from the general population. J Psychiatr Res 2010; 44: 15–21.
9. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109: 1955–1959.
10. Yip H-K, Hang C-L, Fang C-Y, Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005; 127: 803–808.
11. Caixeta A, Stone GW, Mehran R, Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: An analysis from the ACUITY trial. J Thromb Thrombolysis 2011; 31: 154–164.
12. Steptoe A, Molloy GJ, Messerli-Bürgy N, Fear of dying and inflammation following acute coronary syndrome. Eur Heart J 2011; 32: 2405–2411.
13. Meister RE, Weber T, Princip M, Resilience as a correlate of acute stress disorder symptoms in patients with acute myocardial infarction. Open Heart 2015; 2: e000261–e000261.
14. Edmondson D, Mills MA, Park CL. Factor structure of the acute stress disorder scale in a sample of Hurricane Katrina evacuees. Psychol Assess 2010; 22: 269–278.
15. Ginzburg K, Kutz I, Koifman B, Acute stress disorder symptoms predict all-cause mortality among myocardial infarction patients: A 15-year longitudinal study. Ann Behav Med 2016; 50: 177–186.
16. Meister R, Princip M, Schmid J-P, Myocardial Infarction – Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: Study protocol for a randomized controlled trial. Trials 2013; 14: 329–329.
17. Von Känel R, Hari R, Schmid J-P, Distress related to myocardial infarction and cardiovascular outcome: A retrospective observational study. BMC Psychiatry 2011; 11: 98–98.
18. Helfricht S, Landolt MA, Moergeli H, Psychometric evaluation and validation of the German version of the Acute Stress Disorder Scale across two distinct trauma populations. J Trauma Stress 2009; 22: 476–480.
19. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
20. Bryant RA, Moulds ML, Guthrie RM. Acute Stress Disorder Scale: A self-report measure of acute stress disorder. Psychol Assess 2000; 12: 61–68.
21. Mitchell PH, Powell L, Blumenthal J, A short social support measure for patients recovering from myocardial infarction: The ENRICHD Social Support Inventory. J Cardiopulm Rehabil 2003; 23: 398–403.
22. Bopp M, Minder CE. Swiss National Cohort. Mortality by education in German speaking Switzerland, 1990–1997: Results from the Swiss National Cohort. Int J Epidemiol 2003; 32: 346–354.
23. Bell S, Daskalopoulou M, Rapsomaniki E, Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: Population based cohort study using linked health records. BMJ 2017; 356: j909–j909.
24. Guler E, Schmid J-P, Wiedemar L, Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clin Cardiol 2009; 32: 125–129.
25. Fox KAA, Dabbous OH, Goldberg RJ, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ 2006; 333: 1091–1091.
26. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98: 310–357.
27. Pedersen SS, von Känel R, Tully PJ, Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol 2017; 24(3 Suppl.): 108–115.
28. Barth J, Schneider S, von Känel R. Lack of social support in the etiology and the prognosis of coronary heart disease: A systematic review and meta-analysis. Psychosom Med 2010; 72: 229–238.
29. Heffner KL, Waring ME, Roberts MB, Social isolation, C-reactive protein, and coronary heart disease mortality among community-dwelling adults. Soc Sci Med 2011; 72: 1482–1488.
30. Stein DJ, Koenen KC, Friedman MJ, Dissociation in posttraumatic stress disorder: Evidence from the world mental health surveys. Biol Psychiatry 2013; 73: 302–312.
31. Roberge M-A, Dupuis G, Marchand A. Post-traumatic stress disorder following myocardial infarction: prevalence and risk factors. Can J Cardiol 2010; 26: e170–e175.
32. Pogosova N, Kotseva K, De Bacquer D, Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur J Prev Cardiol 2017; 24: 1371–1380.
33. Li FYL, Cheng KKY, Lam KSL, Cross-talk between adipose tissue and vasculature: Role of adiponectin. Acta Physiol (Oxf) 2011; 203: 167–180.